Phase II/III Study of YM150 - A Placebo-Controlled, Double-Blind, Group Comparison Study in Patients Undergoing Elective Total Hip Replacement Surgery.

Trial Profile

Phase II/III Study of YM150 - A Placebo-Controlled, Double-Blind, Group Comparison Study in Patients Undergoing Elective Total Hip Replacement Surgery.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 01 Mar 2014

At a glance

  • Drugs Darexaban (Primary) ; Enoxaparin sodium
  • Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
  • Focus Registrational; Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 08 Jun 2010 Actual end date added 1 Mar 2010 as reported by ClinicalTrials.gov.
    • 08 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Feb 2010 Actual patient number (610) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top